公司业绩预测
Search documents
益方生物:预计2025年度净利润亏损3.17亿元
Xin Lang Cai Jing· 2026-02-26 10:16
Group 1 - The company expects to achieve operating revenue of 37.3253 million yuan in 2025, with a net profit attributable to the parent company of -317 million yuan [1] - The reported financial data is preliminary and has not been audited by an accounting firm [1] - The performance changes in 2025 are primarily influenced by the intensity of research and development investment and the composition of revenue [1]
皇冠控股2025年Q4业绩公布,分析师预测营收29.93亿美元
Jing Ji Guan Cha Wang· 2026-02-12 22:55
Group 1 - The core viewpoint of the article is that Crown Holdings (CCK) has announced its Q4 2025 earnings, with analysts previously predicting revenue of $2.993 billion and earnings per share of $1.408 [1] - The actual performance data will be confirmed by the company's latest announcement [1] Group 2 - The next significant event for the company is the Q1 2026 earnings release, expected to occur in April 2026, with current analyst revenue forecasts at $2.9754 billion [2] - The company had previously raised its full-year adjusted earnings per share guidance for 2025 to a range of $7.70 to $7.80, although this guidance may be subject to adjustments based on subsequent performance [2]
鸿泉技术(688288.SH):预计2025年度净利润3000万元左右
Ge Long Hui A P P· 2026-01-29 09:35
Group 1 - The company expects to achieve an operating revenue of approximately 700 million yuan in 2025, an increase of about 177 million yuan compared to the previous year, representing a year-on-year growth of approximately 33.79% [1] - The company anticipates a net profit attributable to the parent company of around 30 million yuan for 2025, which would be an increase of approximately 32.94 million yuan compared to the previous year, marking a turnaround from loss to profit [1] - The company projects a net profit attributable to the parent company, excluding non-recurring gains and losses, of about 45 million yuan for 2025, an increase of approximately 52.49 million yuan year-on-year, also indicating a turnaround from loss to profit [1]
*ST华嵘:预计2025年净利润为650-800万元
Ge Long Hui· 2026-01-28 08:08
Core Viewpoint - *ST Huaron (600421.SH) expects to achieve a total profit of 7-8.5 million yuan for the year 2025, indicating a cautious outlook for future profitability [1] Financial Projections - The company anticipates a net profit attributable to shareholders of 6.5-8 million yuan for the year 2025 [1] - The net profit after deducting non-recurring gains and losses is projected to be between 6-7.5 million yuan [1] - Expected operating revenue for 2025 is estimated to be in the range of 185-195 million yuan [1] - After excluding revenue from non-core business activities and income lacking commercial substance, the operating revenue is projected to be 175-185 million yuan [1] - The net assets attributable to shareholders are expected to be between 14.5-16 million yuan by the end of 2025 [1]
*ST华嵘(600421.SH):预计2025年净利润为650-800万元
Ge Long Hui A P P· 2026-01-28 08:02
格隆汇1月28日丨*ST华嵘(600421.SH)公布,经财务部门初步测算,公司预计2025年年度实现的利润总 额为700-850万元,预计2025年年度归属于上市公司股东的净利润为650-800万元,归属于上市公司股东 的扣除非经常性损益的净利润为600-750万元;预计2025年年度营业收入为1.85-1.95亿元,扣除与主营 业务无关的业务收入和不具备商业实质的收入后的营业收入为1.75-1.85亿元;预计2025年末归属于上市 公司股东的净资产为1,450-1,600万元。 ...
昭衍新药:预计2025年归母净利润约2.33亿元到3.49亿元,同比增加约214.0%到371.0%
Ge Long Hui· 2026-01-20 09:00
预计2025年实现归属于上市公司股东的净利润约人民币2.33亿元到人民币3.49亿元,与上年同期的数据 相比,将增加约人民币15,853.52万元到人民币 27,484.06万元,同比增加约214.0%到371.0%。 预计 2025 年实现归属于上市公司股东的扣除非经常性损益的净利润约人民币 24,638.00 万元到人民币 36,956.99 万元,与上年同期的数据相比,将增加约人民币 22,280.66 万元到人民币 34,599.65 万元,同 比增加约945.2%到1,467.7%。 格隆汇1月20日丨昭衍新药(603127.SH)公布,预计2025年实现营业收入约人民币15.73亿元到人民币 17.38亿元,与上年同期的数据相比,将减少约人民币28,019.80 万元到人民币 44,573.47 万元,同比减少 约 13.9%到 22.1%。 ...
杭叉集团(603298.SH):预计2025年归母净利润为21.13亿元至23.15亿元,同比增加4.52%至14.48%
Ge Long Hui A P P· 2026-01-15 10:11
Core Viewpoint - Hangcha Group (603298.SH) expects a significant increase in net profit for 2025, indicating positive growth prospects for the company [1] Financial Performance - The company anticipates a net profit attributable to shareholders of between 2.113 billion and 2.315 billion yuan for 2025, representing an increase of 91.47 million to 292.75 million yuan compared to the previous year, which is a year-on-year growth of 4.52% to 14.48% [1] - When compared to the restated financial data from the previous year, the expected increase in net profit is between 100.64 million and 301.93 million yuan, reflecting a year-on-year growth of 5.00% to 15.00% [1] Non-Recurring Profit - The projected net profit, excluding non-recurring gains and losses, is estimated to be between 2.058 billion and 2.255 billion yuan for 2025, with an expected increase of 69.64 million to 265.93 million yuan compared to the previous year, which translates to a year-on-year growth of 3.50% to 13.37% [1] - Compared to the restated financial data from the previous year, the anticipated increase is between 97.92 million and 294.21 million yuan, indicating a year-on-year growth of 4.99% to 15.01% [1]
迪哲医药:预计2025年度净亏损7.7亿元左右
Ge Long Hui· 2026-01-12 10:36
Group 1 - The company expects to achieve an operating revenue of approximately 800 million yuan in 2025, an increase of about 440.1 million yuan compared to the previous year, representing a year-on-year growth of approximately 122.28% [1] - The estimated R&D expenses for 2025 are around 860 million yuan, which is an increase of about 136.31 million yuan from the previous year, reflecting a year-on-year increase of approximately 18.84% [1] - The projected net loss attributable to the parent company's owners for 2025 is approximately 770 million yuan, a reduction of about 75.96 million yuan compared to the previous year, indicating a year-on-year decrease in loss of approximately 8.98% [1] - The estimated net loss attributable to the parent company's owners, excluding non-recurring gains and losses, is around 850 million yuan for 2025, which is a decrease of about 48.89 million yuan from the previous year, showing a year-on-year reduction in loss of approximately 5.44% [1]
Cisco Systems shares rise in Europe after forecasts upgrade
Reuters· 2025-11-13 07:07
Core Insights - Cisco Systems shares increased by over 8% in early Frankfurt trading following the company's raised full-year forecasts for profit and revenue [1] Company Summary - Cisco Systems has updated its full-year forecasts, indicating a positive outlook for both profit and revenue [1]
Insights Into O'Reilly Automotive (ORLY) Q2: Wall Street Projections for Key Metrics
ZACKS· 2025-07-18 14:15
Core Viewpoint - Analysts expect O'Reilly Automotive to report quarterly earnings of $0.77 per share, reflecting a 10% year-over-year increase, with revenues projected at $4.53 billion, up 6.1% from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions, with empirical research showing a strong correlation between earnings estimate revisions and short-term stock performance [2] Key Metrics Forecast - Sales to Do-It-Yourself Customers are estimated at $2.30 billion, indicating a 6.8% increase from the prior year [4] - Sales to professional service provider customers are projected to be $2.13 billion, reflecting a 6.7% year-over-year increase [5] - Other sales and sales adjustments are expected to reach $108.53 million, showing a decline of 12.1% from the previous year [4] Store Metrics - Total number of stores is expected to reach 6,466, up from 6,244 a year ago [6] - Ending domestic store count is projected at 6,341, compared to 6,152 last year [6] - Number of stores opened is estimated at 48, an increase from 27 in the same quarter last year [6] Additional Store Insights - Domestic new stores opened are forecasted at 40, compared to 21 in the same quarter of the previous year [7] - Estimated Mexico stores at the end of the period is 100, up from 69 last year [7] Sales Performance - Sales per weighted-average square foot are expected to reach $91.58 million, compared to $87.88 million in the same quarter last year [8] - Total stores at the beginning of the period are estimated at 6,416, compared to 6,217 a year ago [8] Stock Performance - Over the past month, O'Reilly Automotive shares have returned +3.7%, while the Zacks S&P 500 composite has changed +5.4% [8] - Currently, O'Reilly Automotive holds a Zacks Rank 3 (Hold), indicating performance may align with the overall market in the near future [8]